{"id":321082,"date":"2026-10-21T16:00:15","date_gmt":"2026-10-21T10:30:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=321082"},"modified":"2026-10-21T16:00:15","modified_gmt":"2026-10-21T10:30:15","slug":"pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/","title":{"rendered":"3 Pharmacy-Led Hospital Group, Imaging Diagnostics and Paediatric Care Stocks With a Strong Future Roadmap: Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare: ROE of 16.9% to 20.5% and FY22 to FY26 revenue CAGR of 14.6% to 15.2%. Prices as of 20 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three hospital and diagnostics stocks to watch are Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare. Their return on equity ranges from 16.9% to 20.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.6% to 15.2%. Apollo Hospitals Enterprise has the highest return on equity at 20.5%, while Rainbow Children&#8217;s Medicare has the fastest revenue growth at 15.2% a year. Prices are based on the 20 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Hospital and diagnostics stocks let investors follow the organised providers that treat and test patients as demand for quality care grows. Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare cover India&#8217;s largest private hospital group, a pathology and imaging chain and a network of paediatric and maternity hospitals.<\/p>\n<p>This list covers three hospital and diagnostics stocks with complete current figures: Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare. Every figure comes from the latest reported financials and the 20 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#What_Are_Hospital_and_Diagnostics_Stocks\" title=\"What Are Hospital and Diagnostics Stocks?\">What Are Hospital and Diagnostics Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Hospital_and_Diagnostics_Stocks_at_a_Glance\" title=\"Hospital and Diagnostics Stocks at a Glance\">Hospital and Diagnostics Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Why_Do_Hospital_and_Diagnostics_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Hospital and Diagnostics Stocks Have a Strong Roadmap in India?\">Why Do Hospital and Diagnostics Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Why_Apollo_Hospitals_Enterprise_Features_Among_These_Hospital_and_Diagnostics_Stocks\" title=\"Why Apollo Hospitals Enterprise Features Among These Hospital and Diagnostics Stocks\">Why Apollo Hospitals Enterprise Features Among These Hospital and Diagnostics Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Why_Vijaya_Diagnostic_Centre_Features_Among_These_Hospital_and_Diagnostics_Stocks\" title=\"Why Vijaya Diagnostic Centre Features Among These Hospital and Diagnostics Stocks\">Why Vijaya Diagnostic Centre Features Among These Hospital and Diagnostics Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Why_Rainbow_Childrens_Medicare_Features_Among_These_Hospital_and_Diagnostics_Stocks\" title=\"Why Rainbow Children&#8217;s Medicare Features Among These Hospital and Diagnostics Stocks\">Why Rainbow Children&#8217;s Medicare Features Among These Hospital and Diagnostics Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Apollo_Hospitals_Enterprise_vs_Vijaya_Diagnostic_Centre_vs_Rainbow_Childrens_Medicare_on_Key_Financials\" title=\"Apollo Hospitals Enterprise vs Vijaya Diagnostic Centre vs Rainbow Children&#8217;s Medicare on Key Financials\">Apollo Hospitals Enterprise vs Vijaya Diagnostic Centre vs Rainbow Children&#8217;s Medicare on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Key_Risks_to_Check_Before_Investing_in_Hospital_and_Diagnostics_Stocks\" title=\"Key Risks to Check Before Investing in Hospital and Diagnostics Stocks\">Key Risks to Check Before Investing in Hospital and Diagnostics Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Final_Thoughts_on_Hospital_and_Diagnostics_Stocks\" title=\"Final Thoughts on Hospital and Diagnostics Stocks\">Final Thoughts on Hospital and Diagnostics Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#What_are_hospital_and_diagnostics_stocks\" title=\"What are hospital and diagnostics stocks?\">What are hospital and diagnostics stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Which_hospital_and_diagnostics_stocks_are_covered_in_this_list\" title=\"Which hospital and diagnostics stocks are covered in this list?\">Which hospital and diagnostics stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Why_do_hospital_and_diagnostics_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do hospital and diagnostics stocks have a strong future roadmap in India?\">Why do hospital and diagnostics stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#How_has_Apollo_Hospitals_Enterprise_performed_financially\" title=\"How has Apollo Hospitals Enterprise performed financially?\">How has Apollo Hospitals Enterprise performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#How_has_Vijaya_Diagnostic_Centre_performed_financially\" title=\"How has Vijaya Diagnostic Centre performed financially?\">How has Vijaya Diagnostic Centre performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#How_has_Rainbow_Childrens_Medicare_performed_financially\" title=\"How has Rainbow Children&#8217;s Medicare performed financially?\">How has Rainbow Children&#8217;s Medicare performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#What_risks_should_investors_check_before_buying_hospital_and_diagnostics_stocks\" title=\"What risks should investors check before buying hospital and diagnostics stocks?\">What risks should investors check before buying hospital and diagnostics stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks-roadmap-ascent-list\/#Is_this_list_of_hospital_and_diagnostics_stocks_investment_advice\" title=\"Is this list of hospital and diagnostics stocks investment advice?\">Is this list of hospital and diagnostics stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Hospital_and_Diagnostics_Stocks\"><\/span><strong>What Are Hospital and Diagnostics Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hospital and diagnostics stocks are listed companies that run hospitals, laboratories and imaging centres on a commercial basis. Their earnings depend on bed capacity, occupancy, the mix of procedures and the volume of tests handled.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Hospital_and_Diagnostics_Stocks_at_a_Glance\"><\/span><strong>Hospital and Diagnostics Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today\">Apollo Hospitals Enterprise<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,700<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">110,757<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">51.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/vijaya\/vijaya-diagnostic-centre-ltd-share-price-today\">Vijaya Diagnostic Centre<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,368.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,066<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">75.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.44<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/rainbow\/rainbow-children's-medicare-ltd-share-price-today\">Rainbow Children&#8217;s Medicare<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,236<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12,554<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">43.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.54<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Apollo Hospitals Enterprise and Rainbow Children&#8217;s Medicare trade at a P\/E below the industry P\/E, while Vijaya Diagnostic Centre trades above it, which reflects the growth the market already expects. Readers comparing hospital and diagnostics stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in hospital and diagnostics stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Hospital_and_Diagnostics_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Hospital and Diagnostics Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hospital and diagnostics stocks have a strong roadmap in India because spending on treatment and early testing is rising faster than the supply of organised beds and imaging centres.<\/p>\n<ul>\n<li><strong>Insurance cover.<\/strong> More insured families choose organised providers for planned care.<\/li>\n<li><strong>Capacity additions.<\/strong> New beds and centres in proven cities lift volumes.<\/li>\n<li><strong>Specialised care.<\/strong> Paediatric, cardiac and imaging services draw repeat patients.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Apollo_Hospitals_Enterprise_Features_Among_These_Hospital_and_Diagnostics_Stocks\"><\/span><strong>Why Apollo Hospitals Enterprise Features Among These Hospital and Diagnostics Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the hospital and diagnostics stocks on this list, Apollo Hospitals Enterprise is India&#8217;s largest private healthcare group, running a network of hospitals along with a pharmacy chain, diagnostics, primary care clinics and a digital health platform.<\/p>\n<p>Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%.<\/p>\n<p>In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore. The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P\/E of 51.0, below the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.<\/p>\n<p><strong>What to watch:<\/strong> Track bed additions and occupancy and the growth of the pharmacy and digital health businesses.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Vijaya_Diagnostic_Centre_Features_Among_These_Hospital_and_Diagnostics_Stocks\"><\/span><strong>Why Vijaya Diagnostic Centre Features Among These Hospital and Diagnostics Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the private hospital shares on this list, Vijaya Diagnostic Centre is a Hyderabad-headquartered diagnostics chain that offers pathology and radiology services through a network of centres, with Hyderabad and Telangana as its home base.<\/p>\n<p>In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%.<\/p>\n<p>Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P\/E of 75.0, above the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> The plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.<\/p>\n<p><strong>What to watch:<\/strong> Check the revenue contribution from newer regions and the pace at which new centres turn profitable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Rainbow_Childrens_Medicare_Features_Among_These_Hospital_and_Diagnostics_Stocks\"><\/span><strong>Why Rainbow Children&#8217;s Medicare Features Among These Hospital and Diagnostics Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Rainbow Children&#8217;s Medicare operates paediatric, neonatal and maternity hospitals under the Rainbow Children&#8217;s Hospital and BirthRight by Rainbow brands, with clusters in Hyderabad, Bengaluru, Chennai and Delhi NCR.<\/p>\n<p>The company has a return on equity of 16.9%, a debt to equity ratio of 0.54 and a market capitalisation of Rs 12,554 crore. The stock trades at a P\/E of 43.2, below the industry P\/E of 59.6.<\/p>\n<p>Revenue rose from Rs 993 crore in FY22 to Rs 1,747 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew from Rs 139 crore in FY22 to Rs 282 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 29.4% year on year to Rs 483 crore, while net profit rose 16.2% to Rs 62.5 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company adds hospitals in a cluster model, so each new site draws referrals from nearby facilities. Its focus on child and women&#8217;s healthcare is a defined niche where few organised competitors operate at scale, which helps both pricing and brand recall.<\/p>\n<p><strong>What to watch:<\/strong> Monitor how fast new clusters in Delhi NCR and other regions reach breakeven.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Apollo_Hospitals_Enterprise_vs_Vijaya_Diagnostic_Centre_vs_Rainbow_Childrens_Medicare_on_Key_Financials\"><\/span><strong>Apollo Hospitals Enterprise vs Vijaya Diagnostic Centre vs Rainbow Children&#8217;s Medicare on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three hospital and diagnostics stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Apollo Hospitals Enterprise<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,741<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25,420<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,003<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Vijaya Diagnostic Centre<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">475<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">835<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">173<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Rainbow Children&#8217;s Medicare<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">993<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,747<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">282<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Apollo Hospitals Enterprise posts the highest return on equity in this group at 20.5%. Apollo Hospitals Enterprise has the largest FY26 revenue at Rs 25,420 crore, and Rainbow Children&#8217;s Medicare shows the fastest revenue growth with a 15.2% compound annual rate. A useful habit with hospital and diagnostics stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several imaging and paediatric care stocks instead of one name, which keeps a single result from deciding the outcome.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Apollo Hospitals Enterprise<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,882<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,092<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Vijaya Diagnostic Centre<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">195<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">240<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Rainbow Children&#8217;s Medicare<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">373<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">483<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Hospital_and_Diagnostics_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Hospital and Diagnostics Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these hospital and diagnostics stocks, the main points are: Long-term private hospital shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Ramp-up timing.<\/strong> New hospitals take time to reach stable occupancy.<\/li>\n<li><strong>Doctor availability.<\/strong> Expert doctors are central to growth and hard to attract.<\/li>\n<li><strong>Valuation levels.<\/strong> Some of these companies trade at high earnings multiples, so growth must continue to justify them.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter hospital and diagnostics stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Hospital_and_Diagnostics_Stocks\"><\/span><strong>Final Thoughts on Hospital and Diagnostics Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hospital and diagnostics stocks reward investors who follow bed additions, occupancy and test volumes together. Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare each have a visible expansion path. Based on the 20 October 2026 close, Apollo Hospitals Enterprise trades at Rs 7,700, Vijaya Diagnostic Centre at Rs 1,368.2 and Rainbow Children&#8217;s Medicare at Rs 1,236. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these hospital and diagnostics stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track hospital and diagnostics stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_hospital_and_diagnostics_stocks\"><\/span><strong>What are hospital and diagnostics stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Hospital and diagnostics stocks are listed companies that run hospitals, laboratories and imaging centres on a commercial basis. Their earnings depend on bed capacity, occupancy, the mix of procedures and the volume of tests handled. This list looks at three of them, Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare, using reported FY22 to FY26 financials and the 20 October 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_hospital_and_diagnostics_stocks_are_covered_in_this_list\"><\/span><strong>Which hospital and diagnostics stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare. Based on the 20 October 2026 close, Apollo Hospitals Enterprise traded at Rs 7,700, Vijaya Diagnostic Centre at Rs 1,368.2 and Rainbow Children&#8217;s Medicare at Rs 1,236. Their return on equity ranges from 16.9% to 20.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.6% to 15.2%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_hospital_and_diagnostics_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do hospital and diagnostics stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Hospital and diagnostics stocks have a strong roadmap in India because spending on treatment and early testing is rising faster than the supply of organised beds and imaging centres. The main drivers are as follows. Insurance cover. More insured families choose organised providers for planned care. Capacity additions. New beds and centres in proven cities lift volumes. Specialised care. Paediatric, cardiac and imaging services draw repeat patients. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Apollo_Hospitals_Enterprise_performed_financially\"><\/span><strong>How has Apollo Hospitals Enterprise performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore. The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P\/E of 51.0, below the industry P\/E of 59.6. Looking ahead, the company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Vijaya_Diagnostic_Centre_performed_financially\"><\/span><strong>How has Vijaya Diagnostic Centre performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P\/E of 75.0, above the industry P\/E of 59.6. Looking ahead, the plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Rainbow_Childrens_Medicare_performed_financially\"><\/span><strong>How has Rainbow Children&#8217;s Medicare performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 993 crore in FY22 to Rs 1,747 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew from Rs 139 crore in FY22 to Rs 282 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 29.4% year on year to Rs 483 crore, while net profit rose 16.2% to Rs 62.5 crore. The company has a return on equity of 16.9%, a debt to equity ratio of 0.54 and a market capitalisation of Rs 12,554 crore. The stock trades at a P\/E of 43.2, below the industry P\/E of 59.6. Looking ahead, the company adds hospitals in a cluster model, so each new site draws referrals from nearby facilities. Its focus on child and women&#8217;s healthcare is a defined niche where few organised competitors operate at scale, which helps both pricing and brand recall.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_hospital_and_diagnostics_stocks\"><\/span><strong>What risks should investors check before buying hospital and diagnostics stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying hospital and diagnostics stocks. Ramp-up timing. New hospitals take time to reach stable occupancy. Doctor availability. Expert doctors are central to growth and hard to attract. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_hospital_and_diagnostics_stocks_investment_advice\"><\/span><strong>Is this list of hospital and diagnostics stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 20 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are hospital and diagnostics stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hospital and diagnostics stocks are listed companies that run hospitals, laboratories and imaging centres on a commercial basis. Their earnings depend on bed capacity, occupancy, the mix of procedures and the volume of tests handled. This list looks at three of them, Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children's Medicare, using reported FY22 to FY26 financials and the 20 October 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which hospital and diagnostics stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children's Medicare. Based on the 20 October 2026 close, Apollo Hospitals Enterprise traded at Rs 7,700, Vijaya Diagnostic Centre at Rs 1,368.2 and Rainbow Children's Medicare at Rs 1,236. Their return on equity ranges from 16.9% to 20.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.6% to 15.2%.\"}},{\"@type\":\"Question\",\"name\":\"Why do hospital and diagnostics stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hospital and diagnostics stocks have a strong roadmap in India because spending on treatment and early testing is rising faster than the supply of organised beds and imaging centres. The main drivers are as follows. Insurance cover. More insured families choose organised providers for planned care. Capacity additions. New beds and centres in proven cities lift volumes. Specialised care. Paediatric, cardiac and imaging services draw repeat patients. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Apollo Hospitals Enterprise performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore. The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P\/E of 51.0, below the industry P\/E of 59.6. Looking ahead, the company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.\"}},{\"@type\":\"Question\",\"name\":\"How has Vijaya Diagnostic Centre performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P\/E of 75.0, above the industry P\/E of 59.6. Looking ahead, the plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.\"}},{\"@type\":\"Question\",\"name\":\"How has Rainbow Children's Medicare performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 993 crore in FY22 to Rs 1,747 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew from Rs 139 crore in FY22 to Rs 282 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 29.4% year on year to Rs 483 crore, while net profit rose 16.2% to Rs 62.5 crore. The company has a return on equity of 16.9%, a debt to equity ratio of 0.54 and a market capitalisation of Rs 12,554 crore. The stock trades at a P\/E of 43.2, below the industry P\/E of 59.6. Looking ahead, the company adds hospitals in a cluster model, so each new site draws referrals from nearby facilities. Its focus on child and women's healthcare is a defined niche where few organised competitors operate at scale, which helps both pricing and brand recall.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying hospital and diagnostics stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying hospital and diagnostics stocks. Ramp-up timing. New hospitals take time to reach stable occupancy. Doctor availability. Expert doctors are central to growth and hard to attract. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of hospital and diagnostics stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 20 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hospital and Diagnostics Stocks with a strong future roadmap: Apollo Hospitals Enterprise, Vijaya Diagnostic Centre and Rainbow Children&#8217;s Medicare. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.<\/p>\n","protected":false},"author":35,"featured_media":321081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[14049,3803,10052,14048,14047,9128,8585],"class_list":["post-321082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-apollo-hospitals-enterprise","tag-best-stocks","tag-hospital-and-diagnostics-stocks","tag-imaging-and-paediatric-care-stocks","tag-private-hospital-shares","tag-rainbow-childrens-medicare","tag-vijaya-diagnostic-centre"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["321081"],"rank_math_title":["Hospital and Diagnostics Stocks With a Strong Roadmap"],"rank_math_description":["Compare 3 hospital and diagnostics stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 20 Oct 2026."],"rank_math_focus_keyword":["hospital and diagnostics stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-pharmacy-led-hospital-group-imaging-diagnostics-and-paediatric-care-stocks.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/321082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=321082"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/321082\/revisions"}],"predecessor-version":[{"id":321083,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/321082\/revisions\/321083"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/321081"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=321082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=321082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=321082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}